Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Casein derived peptides and therapeutic uses thereof

A casein, chimeric peptide technology, applied in the fields of peptide/protein composition, animal protein processing, peptide, etc., can solve the problem of not mentioning the application of protein fragments

Inactive Publication Date: 2008-02-13
PEPTERA PHARMA LTD
View PDF10 Cites 21 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0029] Previous studies have documented that potentially bioactive peptides are encoded in the N-terminus of αS1-casein, αS2-casein, β-casein, and κ-casein in the amino acid sequences, but did not mention the application, specific Sequence or defined synthetic peptides, alone or in combination, to enhance hematopoiesis, protect against viral infection, or modulate the development of autoimmune diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Casein derived peptides and therapeutic uses thereof
  • Casein derived peptides and therapeutic uses thereof
  • Casein derived peptides and therapeutic uses thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0310] Reference is now made to the following examples, which together with the above description explain the invention in a non-limiting form.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
Login to View More

Abstract

Biologically active peptides that are derived from or are similar to sequences of the alphaS1-, alphaS2-, beta- or kapa-casein fractions of milk casein. These peptides are capable of immune modulation and other therapeutic activities, including but not limited to stimulating and enhancing immune response, protecting against viral infection, normalizing serum cholesterol levels, and stimulating hematopoiesis. The casein-derived peptides are non-toxic and can be used to treat and prevent immune pathologies, diabetes, hypercholesterolemia, hematological disorders and viral-related diseases.

Description

Technical field [0001] The present invention relates to biologically active peptides derived from or similar to the sequence of αS1-, αS2-, β- or κ-casein fragments of casein. These peptides can immunomodulate and other therapeutic activities, including but not limited to stimulating and enhancing immune responses, preventing viral infections, normalizing serum cholesterol levels, and stimulating hematopoiesis. Casein-derived peptides are non-toxic and can be used to treat and prevent immunopathology, diabetes, hypercholesterolemia, hematopoietic diseases and virus-related diseases. Background technique [0002] Bioactive molecules from nutrients: [0003] In addition to the nutritional value of many foods, certain fragments and products of the digestive pathway have the ability to affect physiological processes. Some of these "extra-nutritive" ingredients are present in their entire nutrients in their active form, such as immunoglobulins in breast milk and colostrum, phytoestrog...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C08H1/04A23J3/10A61K38/16A61K38/00
CPCA61K38/00C07K14/4732A61P3/00A61P3/06A61P3/08A61P3/10A61P7/00A61P7/04A61P7/06A61P31/00A61P31/04A61P31/12A61P31/18A61P37/00A61P37/04A61P37/06A61P43/00A61K38/17C07K14/435
Inventor Z·斯德尔曼
Owner PEPTERA PHARMA LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products